Synthesis of discrete and dispersible hollow mesoporous silica nanoparticles with tailored shell thickness for controlled drug release

By employing poly (tert-butylacrylate) (PTBA) nanospheres as the dissolvable core templates, we develop a new method to synthesize hollow mesoporous silica nanoparticles (HMSN). Both the PTBA core and the structure-directing surfactant, cetyltrimethylammonium bromide (CTAB), can be easily and synchronously removed through solvent extraction in ethanol, which ensures the complete structure and ideal dispersibility of the products compared with the previous template synthesis that often needs calcination to remove the templates. Given that hollow core diameter and shell thickness are the key properties of HMSN, the hollow core diameter and shell thickness can be tailored precisely. In addition, as novel inorganic nanomaterials with a tuned structure, HMSN show notable biocompatibility and efficient doxorubicin (DOX) loading. In in vitro tests, the release rate of DOX-loaded HMSN exhibit a surprising shell-thickness-dependent and a pH responsive drug release character, suggesting that HMSN are a very promising drug delivery system for shell-thickness-controlled drug release. The results of intracellular tracking and cytotoxicity assays further demonstrate the potential and efficiency of HMSN as a drug delivery system.

[1]  Y. Yeh,et al.  Synthesis of hollow silica spheres with mesostructured shell using cationic-anionic-neutral block copolymer ternary surfactants. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[2]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  J. F. Stoddart,et al.  Controlled-access hollow mechanized silica nanocontainers. , 2009, Journal of the American Chemical Society.

[4]  S. Rankin,et al.  Dual latex/surfactant templating of hollow spherical silica particles with ordered mesoporous shells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[5]  J. Rosenholm,et al.  Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Dong Chen,et al.  In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.

[7]  Transmission electron microscopy — an indispensable tool for the characterisation of M41S-type materials. , 2000 .

[8]  Xinwen Guo,et al.  Hollow Silica Spheres with a Novel Mesoporous Shell Perforated Vertically by Hexagonally Arrayed Cylindrical Nanochannels , 2009 .

[9]  Yaping Li,et al.  Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. , 2011, ACS nano.

[10]  Baohui Li,et al.  Budded, Mesoporous Silica Hollow Spheres: Hierarchical Structure Controlled by Kinetic Self‐Assembly , 2006 .

[11]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[12]  Emmanuel P. Giannelis,et al.  Facile and Scalable Synthesis of Monodispersed Spherical Capsules with a Mesoporous Shell , 2010 .

[13]  C. Mou,et al.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.

[14]  Yufang Zhu,et al.  Hollow mesoporous spheres with cubic pore network as a potential carrier for drug storage and its in vitro release kinetics , 2005 .

[15]  Jianhua Hu,et al.  Magnetic mesoporous silica microspheres with thermo-sensitive polymer shell for controlled drug release , 2009 .

[16]  Wenxin Wang,et al.  Synthesis of mesoporous silica hollow spheres in supercritical CO2/water systems , 2006 .

[17]  M. Vallet‐Regí,et al.  Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .

[18]  J. Fei,et al.  Preparation of polymer-coated mesoporous silica nanoparticles used for cellular imaging by a “graft-from” method , 2008 .

[19]  F. Zhang,et al.  Rational synthesis of magnetic thermosensitive microcontainers as targeting drug carriers. , 2009, Small.

[20]  Yufang Zhu,et al.  A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property , 2005 .

[21]  A. Stein,et al.  Synthesis of Ordered Microporous Silicates with Organosulfur Surface Groups and Their Applications as Solid Acid Catalysts , 1998 .

[22]  L. Archer,et al.  Hollow Micro‐/Nanostructures: Synthesis and Applications , 2008 .

[23]  María Vallet-Regí,et al.  New developments in ordered mesoporous materials for drug delivery , 2010 .

[24]  Jenny Andersson,et al.  Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices , 2004 .

[25]  Yu Chen,et al.  Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. , 2010, ACS nano.

[26]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[27]  Nicholas A Peppas,et al.  Higuchi equation: derivation, applications, use and misuse. , 2011, International journal of pharmaceutics.

[28]  Jia Guo,et al.  Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. , 2011, International journal of pharmaceutics.

[29]  T. Bein,et al.  Colloidal Suspensions of Nanometer‐Sized Mesoporous Silica , 2007 .

[30]  Victor S-Y Lin,et al.  Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.

[31]  Jane F. Bertone,et al.  A lost-wax approach to monodisperse colloids and their crystals. , 2001, Science.

[32]  J. Fei,et al.  Self‐Assembly of Peptide‐Inorganic Hybrid Spheres for Adaptive Encapsulation of Guests , 2010, Advanced materials.

[33]  Yaping Li,et al.  Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. , 2009, Small.

[34]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[35]  G. Lu,et al.  Periodic mesoporous organosilica hollow spheres with tunable wall thickness. , 2006, Journal of the American Chemical Society.

[36]  M. Vallet‐Regí,et al.  Drug confinement and delivery in ceramic implants. , 2007, Drug metabolism letters.

[37]  Helmuth Möhwald,et al.  One-pot synthesis of polypeptide-gold nanoconjugates for in vitro gene transfection. , 2012, ACS nano.

[38]  Jianfang Wang,et al.  Plasmon-modulated light scattering from gold nanocrystal-decorated hollow mesoporous silica microspheres. , 2010, ACS nano.

[39]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as nanocarriers. , 2011, Chemical communications.

[40]  D. Vos,et al.  1,5,7-Triazabicyclo[4.4.0]dec-5-ene Immobilized in MCM-41: A Strongly Basic Porous Catalyst† , 1997 .

[41]  Vincent M Rotello,et al.  Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. , 2008, ACS nano.

[42]  Xinglu Huang,et al.  Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. , 2011, Biomaterials.

[43]  A. Gedanken,et al.  Acoustic cavitation leading to the morphosynthesis of mesoporous silica vesicles , 2002 .

[44]  B. Rollins,et al.  Chronic expression of monocyte chemoattractant protein‐1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  C. Mou,et al.  Synthesis and Characterization of Positive‐Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti‐Inflammatory Drug , 2008 .

[46]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Sing.  Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984) , 1985 .

[48]  Jean-Marie Devoisselle,et al.  Solid-State NMR Study of Ibuprofen Confined in MCM-41 Material , 2006 .

[49]  A. Tuel,et al.  A Fast and Efficient Ion-Exchange Procedure To Remove Surfactant Molecules from MCM-41 Materials , 2004 .

[50]  Jia Guo,et al.  Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release , 2011 .

[51]  Jia Guo,et al.  Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release , 2010 .

[52]  N. Kato,et al.  Synthesis of monodisperse mesoporous silica hollow microcapsules and their release of loaded materials. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[53]  Juan L. Vivero-Escoto,et al.  Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. , 2010, Biomaterials.

[54]  B. Han,et al.  Synthesis of uniform hollow silica spheres with ordered mesoporous shells in a CO2 induced nanoemulsion. , 2009, Chemical communications.

[55]  Alfredo Sánchez,et al.  Preparation, characterization, and Zn(2+) adsorption behavior of chemically modified MCM-41 with 5-mercapto-1-methyltetrazole. , 2007, Journal of colloid and interface science.

[56]  Feng Chen,et al.  Multifunctional Mesoporous Nanoellipsoids for Biological Bimodal Imaging and Magnetically Targeted Delivery of Anticancer Drugs , 2011 .

[57]  Arun K Iyer,et al.  Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma , 2009, BMC Cancer.

[58]  Sandhya M. Vyas,et al.  Fluorinated‐Surfactant‐Templated Synthesis of Hollow Silica Particles with a Single Layer of Mesopores in Their Shells , 2005 .

[59]  Wei-Hsuan Chen,et al.  The FASEB Journal express article 10.1096/fj.05-4288fje. Published online October 17, 2005. , 2022 .

[60]  C. Sanchez,et al.  Elaboration of monodisperse spherical hollow particles with ordered mesoporous silica shells via dual latex/surfactant templating: radial orientation of mesopore channels. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[61]  Zongxi Li,et al.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.

[62]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[63]  A. Lefebvre,et al.  SiOH-Functionalized Polystyrene Latexes. A Step toward the Synthesis of Hollow Silica Nanoparticles , 2002 .

[64]  Eryun Yan,et al.  Polymer/silica hybrid hollow nanospheres with pH-sensitive drug release in physiological and intracellular environments. , 2009, Chemical communications.